Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8).
Jacobs
Avrum
A
Department of Internal Medicine, Division of Cardiology, University of Chicago, Illinois 60637, USA.
Knight
Bradley P
BP
McDonald
Karen T
KT
Burke
Martin C
MC
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D006323:Heart Arrest / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008133:Long QT Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D012086:Reoperation; D013575:Syncope / Q000188:drug therapy / Q000209:etiology; D014693:Ventricular Fibrillation / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014700:Verapamil / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D014700:Verapamil; D008790:Metoprolol